Last update :
21/02/2024
Local anesthetic   Lidocaine hydrochloride  
Injection
Mouthwash Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Jetokaine Turkey
Lidocard Finland
Lidocorit Austria
Lidosen Italy
Lidrian Italy
Linisol Belgium
Locaine Republic of South Africa
Minijet lignocaine Great Britain
Pisacaina Ecuador, Mexico
Plidocain Poland
Rapidocain Switzerland
Remicaine Republic of South Africa
Remicard Republic of South Africa
Xilina Romania
Xylanest Austria
Xylesine Switzerland
Xylestesin Brazil
Xylocain Austria, Canada, Denmark, Finland, Norway, Poland, Sweden, Switzerland
Xylocaina Brazil, Italy
Xylocaine Australia, Belgium, Canada, France, Greece, Luxembourg, Malaysia, Morocco, Netherlands, Slovenia, United States of America
Xylocard Australia, Austria, Belgium, Canada, Egypt, France, Portugal, Saudi Arabia, Sweden
Xylocitin Germany
Xyloneural Austria, Switzerland
Stability of mixtures   Injection   Stability of mixtures : Lidocaine hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
25°C
48 Hour
Light 705
Glass NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
40°C
48 Hour
Protect from light 705
Glass NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
4°C
7 Day
Protect from light 705
Glass Glucose 5% 3,26 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Dopamine hydrochloride 0,8 mg/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Glucose 5% 5,3 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
Light 2279
Level of evidence A+
Glass None 9,1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,6 mg/ml
23°C
91 Day
Light 3263
Glass None 9,1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,6 mg/ml
5°C
91 Day
Protect from light 3263
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.5 & 10 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Tirofiban 25 µg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
25°C
48 Hour
Light 705
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
40°C
48 Hour
Protect from light 705
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
4°C
7 Day
Protect from light 705
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 & 8 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Ranitidine hydrochloride 0,05 & 2 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 4 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Flumazenil 0,02 mg/ml
23°C
24 Hour
Light 187
Level of evidence A
Polypropylene Water for Injection 10 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Ceftriaxone disodium 450 mg/ml
-15°C
56 Day
Protect from light 279
Level of evidence B+
Polypropylene Water for Injection 10 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Ceftriaxone disodium 450 mg/ml
20°C
24 Hour
Protect from light 279
Level of evidence B+
Polypropylene Water for Injection 10 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Ceftriaxone disodium 450 mg/ml
4°C
10 Day
Protect from light 279
Level of evidence B+
Polypropylene Sodium chloride 0,9% 3,5 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Epinephrine hydrochloride 3,5 µg/ml
Injection   Bleomycin sulfate 0,75 mg/ml
22°C
1 Day
Not specified 3420
Level of evidence A
Polypropylene Sodium chloride 0,9% 3,5 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Epinephrine hydrochloride 3,5 µg/ml
Injection   Bleomycin sulfate 0,75 mg/ml
4°C
3 Day
Not specified 3420
Level of evidence A
Polypropylene None 9 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,8 mg/ml
Injection   Epinephrine hydrochloride 9 µg/ml
4-7°C
7 Day
Protect from light 2878
Level of evidence B
Polypropylene None 18 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,8 mg/ml
Injection   Epinephrine hydrochloride 9 µg/ml
4-7°C
7 Day
Protect from light 2878
Level of evidence B
Polypropylene None 9 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,8 mg/ml
4-7°C
28 Day
Protect from light 2878
Level of evidence B
Polypropylene None 18 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Sodium bicarbonate 7,8 mg/ml
4-7°C
28 Day
Protect from light 2878
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 20 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Ketamine hydrochloride 2,5 mg/ml
28°C
48 Hour
Protect from light 4350
Level of evidence A+
Polypropylen Syringe None 455 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Magnesium sulfate 2 mg/ml
25°C
168 Day
Protect from light 4457
Level of evidence A
Polypropylen Syringe None 455 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Magnesium sulfate 2 mg/ml
40°C
168 Day
Protect from light 4457
Level of evidence A
Not specified Sodium chloride 0,9% 3,3 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Daptomycin 16,7 mg/ml
22°C-28°C
2 Hour
Not specified 1937
Level of evidence C+
Not specified Water for injection + antibacterial 20 mg/ml
Injection   Lidocaine hydrochloride   
Injection   Phenylephrine hydrochloride 2,5 mg/ml
25°C
66 Day
Not specified 1331
Level of evidence C

  Mentions Légales